Li W, Lin S, Yue L, Fang Y, Xiao S
Front Endocrinol (Lausanne). 2022; 13:742474.
PMID: 35432207
PMC: 9011101.
DOI: 10.3389/fendo.2022.742474.
Giordano G, Bucci P, Mucci A, Pezzella P, Galderisi S
Front Psychiatry. 2022; 12:789179.
PMID: 35002807
PMC: 8727372.
DOI: 10.3389/fpsyt.2021.789179.
Sommer I, Tiihonen J, van Mourik A, Tanskanen A, Taipale H
NPJ Schizophr. 2020; 6(1):12.
PMID: 32358572
PMC: 7195359.
DOI: 10.1038/s41537-020-0102-z.
Sowers M, Di Re J, Wadsworth P, Shavkunov A, Lichti C, Zhang K
Proteomes. 2019; 7(1).
PMID: 30678040
PMC: 6473632.
DOI: 10.3390/proteomes7010005.
Quattrone D, Di Forti M, Gayer-Anderson C, Ferraro L, Jongsma H, Tripoli G
Psychol Med. 2018; 49(8):1378-1391.
PMID: 30282569
PMC: 6518388.
DOI: 10.1017/S0033291718002131.
Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders.
Pinares-Garcia P, Stratikopoulos M, Zagato A, Loke H, Lee J
Brain Sci. 2018; 8(8).
PMID: 30104506
PMC: 6120011.
DOI: 10.3390/brainsci8080154.
Quality of Life and Explanatory Models of Illness in Patients with Schizophrenia.
Jacob J, Kuruvilla A
Indian J Psychol Med. 2018; 40(4):328-334.
PMID: 30093743
PMC: 6065140.
DOI: 10.4103/IJPSYM.IJPSYM_144_18.
Psychotic-Like Experiences at the Healthy End of the Psychosis Continuum.
Unterrassner L, Wyss T, Wotruba D, Ajdacic-Gross V, Haker H, Rossler W
Front Psychol. 2017; 8:775.
PMID: 28555120
PMC: 5431212.
DOI: 10.3389/fpsyg.2017.00775.
Sex differences in the course of schizophrenia across diverse regions of the world.
Novick D, Montgomery W, Treuer T, Moneta M, Haro J
Neuropsychiatr Dis Treat. 2016; 12:2927-2939.
PMID: 27881918
PMC: 5115683.
DOI: 10.2147/NDT.S101151.
The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data.
Savill M, Orfanos S, Bentall R, Reininghaus U, Wykes T, Priebe S
Psychiatry Res. 2016; 247:73-78.
PMID: 27871030
PMC: 5191935.
DOI: 10.1016/j.psychres.2016.11.020.
Clinical Utility and Lifespan Profiling of Neurological Soft Signs in Schizophrenia Spectrum Disorders.
Chan R, Xie W, Geng F, Wang Y, Lui S, Wang C
Schizophr Bull. 2015; 42(3):560-70.
PMID: 26712863
PMC: 4838107.
DOI: 10.1093/schbul/sbv196.
Family Functioning in First-Episode and Chronic Psychosis: The Role of Patient's Symptom Severity and Psychosocial Functioning.
Koutra K, Triliva S, Roumeliotaki T, Basta M, Lionis C, Vgontzas A
Community Ment Health J. 2015; 52(6):710-23.
PMID: 26286079
DOI: 10.1007/s10597-015-9916-y.
Sex-Specific Patterns of Aberrant Brain Function in First-Episode Treatment-Naive Patients with Schizophrenia.
Lei W, Li M, Deng W, Zhou Y, Ma X, Wang Q
Int J Mol Sci. 2015; 16(7):16125-43.
PMID: 26193256
PMC: 4519942.
DOI: 10.3390/ijms160716125.
Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data.
Kuwabara H, Saito Y, Mahlich J
Neuropsychiatr Dis Treat. 2015; 11:935-40.
PMID: 25897229
PMC: 4389915.
DOI: 10.2147/NDT.S81677.
Functional variants in DPYSL2 sequence increase risk of schizophrenia and suggest a link to mTOR signaling.
Liu Y, Pham X, Zhang L, Chen P, Burzynski G, McGaughey D
G3 (Bethesda). 2014; 5(1):61-72.
PMID: 25416705
PMC: 4291470.
DOI: 10.1534/g3.114.015636.
Association of psychopathology with quality of life in acute phase of schizophrenia; an experience from east India.
Patra S, Mishra A
Ind Psychiatry J. 2013; 21(2):104-8.
PMID: 24250041
PMC: 3830157.
DOI: 10.4103/0972-6748.119595.
Gender differences in coerced patients with schizophrenia.
Nawka A, Kalisova L, Raboch J, Giacco D, Cihal L, Onchev G
BMC Psychiatry. 2013; 13:257.
PMID: 24118928
PMC: 3852852.
DOI: 10.1186/1471-244X-13-257.
Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.
Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J
Schizophr Res Treatment. 2012; 2012:916198.
PMID: 22966451
PMC: 3420456.
DOI: 10.1155/2012/916198.
A comparative, developmental, and clinical perspective of neurobehavioral sexual dimorphisms.
Viveros M, Mendrek A, Paus T, Lopez-Rodriguez A, Marco E, Yehuda R
Front Neurosci. 2012; 6:84.
PMID: 22701400
PMC: 3372960.
DOI: 10.3389/fnins.2012.00084.
Automated Facial Action Coding System for dynamic analysis of facial expressions in neuropsychiatric disorders.
Hamm J, Kohler C, Gur R, Verma R
J Neurosci Methods. 2011; 200(2):237-56.
PMID: 21741407
PMC: 3402717.
DOI: 10.1016/j.jneumeth.2011.06.023.